Chester County News and Community Website
NEW HOPE, PA — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) announced that its atrioventricular interval modulation (AVIM) therapy has received Breakthrough Device Designation (BDD) from the U.S. Food and Drug …
Orchestra BioMed Secures FDA Breakthrough Device Designation for AVIM Therapy Read More NEW HOPE, PA — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) has announced its financial results for 2024, alongside major updates on its clinical programs and corporate strategy. The company has demonstrated …
Orchestra BioMed Reports 2024 Financial Results and Advances Cardiovascular Therapy Read More NEW HOPE, PA — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO), a biomedical technology company pioneering high-impact therapeutic solutions, announced its participation in several key investor conferences slated for late February and …
Orchestra BioMed to Participate in Upcoming Investor Conferences Read More NEW HOPE, PA — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) has announced the appointment of Vivek Reddy, M.D., as Executive Chairman of the BACKBEAT Study Steering Committee and Chairman of its …
Dr. Vivek Reddy Joins Orchestra BioMed to Lead Breakthrough Hypertension Study Read More NEW HOPE, PA — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) revealed promising new findings on its atrioventricular interval modulation (AVIM) therapy during a late-breaking presentation at the Technology and Heart Failure …
Orchestra BioMed Unveils Groundbreaking Data on AVIM Therapy’s Potential to Prevent Heart Failure Read More NEW HOPE, PA — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) has announced the appointment of Christopher Cleary as an independent member of its Board of Directors, effective January 30, 2025. A …
Orchestra BioMed Welcomes Christopher Cleary to Board of Directors Read MoreNEW HOPE, PA — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) this week announced its third quarter financial results for 2024, alongside significant updates on its clinical programs. The company is …
Orchestra BioMed Reports Q3 2024 Results, Advances Key Clinical Programs Read More NEW HOPE, PA — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) recently reported its financial results for the second quarter ended June 30, 2024, alongside significant business developments. The company is …
Orchestra BioMed Holdings Reports Second Quarter 2024 Financial Results and Business Updates Read More NEW HOPE, PA — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) has added John Mack to its Board of Directors, effective from July 29, 2024. Mack brings over 30 years of …
Orchestra BioMed Appoints John Mack to Board of Directors Read More NEW HOPE, PA — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) will host an in-person R&D day at the Lotte New York Palace Hotel on Tuesday, June 11, 2024, at 10:00 …
Orchestra BioMed to Showcase Breakthrough Hypertension Therapy at R&D Day Read More